(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are MAGNORA, OREGE, and ATENOR.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| MAGNORA (MGN.OL) | 30.00 | 7.91% | 2023-06-09 08:31:12 |
| OREGE (OREGE.PA) | 0.22 | 6.37% | 2023-06-09 11:01:15 |
| ATENOR (ATEB.BR) | 28.50 | 6.34% | 2023-06-09 11:05:48 |
| CM.COM (CMCOM.AS) | 9.80 | 6.18% | 2023-06-09 11:01:36 |
| NORTHERN DRILLING (NODL.OL) | 27.70 | 5.73% | 2023-06-09 08:31:54 |
| BELYSSE GROUP (BELYS.BR) | 1.18 | 4.91% | 2023-06-09 08:05:49 |
| THUNDERBIRD (TBIRD.AS) | 0.07 | 4.84% | 2023-06-09 08:04:34 |
| AIRTHINGS (AIRX.OL) | 2.58 | 4.67% | 2023-06-09 08:19:55 |
| SCOR SE (SCR.PA) | 24.43 | 4% | 2023-06-09 11:02:58 |
| AKVA GROUP (AKVA.OL) | 63.00 | 3.96% | 2023-06-09 08:20:11 |
The three biggest losers today are AERKOMM INC, NORDIC NANOVECTOR, and GENTIAN DIAGNOSTIC.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| AERKOMM INC (AKOM.PA) | 2.16 | -26.53% | 2023-06-09 08:35:58 |
| NORDIC NANOVECTOR (NANOV.OL) | 2.29 | -18.68% | 2023-06-09 08:31:39 |
| GENTIAN DIAGNOSTIC (GENT.OL) | 42.00 | -8.1% | 2023-06-09 08:30:09 |
| EUROCASTLE INVEST. (ECT.AS) | 6.45 | -7.86% | 2023-06-09 11:02:21 |
| IMCD (IMCD.AS) | 133.35 | -7.07% | 2023-06-09 11:03:03 |
| EASE2PAY NV (EAS2P.AS) | 0.80 | -5.88% | 2023-06-09 11:02:02 |
| LAVIDE HOLDING (LVIDE.AS) | 0.32 | -5.88% | 2023-06-09 11:03:18 |
| ABIVAX (ABVX.PA) | 15.12 | -5.5% | 2023-06-09 08:35:24 |
| MARTIFER (MAR.LS) | 1.07 | -4.91% | 2023-06-09 08:19:05 |
| HYDROGENPRO (HYPRO.OL) | 30.45 | -4.84% | 2023-06-09 08:30:32 |
Winners today
1. MAGNORA (MGN.OL)
7.91% Price Change
Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with MAGNORA jumping 7.91% to €30.00 on Friday while Oslo Børs Benchmark Index_GI rose 0.31% to €1,231.56.
Earnings Per Share
As for profitability, MAGNORA has a trailing twelve months EPS of kr0.78.
PE Ratio
MAGNORA has a trailing twelve months price to earnings ratio of 38.46. Meaning, the purchaser of the share is investing kr38.46 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
Sales Growth
MAGNORA’s sales growth for the next quarter is 1006.5%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MAGNORA’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 331.6%, now sitting on 104.3M for the twelve trailing months.
More news about MAGNORA.
2. OREGE (OREGE.PA)
6.37% Price Change
Orege Société Anonyme designs, develops, operates, manufactures, and markets municipal and industrial sludge, and effluents treatment solutions in France, the United States, Japan, Germany, and the United Kingdom. The company offers SLG solution for conditioning, treating, and recovering municipal and industrial sludge; SLG-F, a combination of SLG conditioning solution; and Flosep for sludge separation and thickening tool. It also provides after-sales, installation and commissioning, operator training, warranty extensions, maintenance, and process line optimization services. The company was incorporated in 2005 and is headquartered in Voisins-Le-Bretonneux, France. Orege Société Anonyme is a subsidiary of Eren Groupe SA.
CAC 40 ended the session with OREGE jumping 6.37% to €0.22 on Friday, after three successive sessions in a row of losses. CAC 40 dropped 0.12% to €7,213.14, following the last session’s upward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, OREGE has a trailing twelve months EPS of €-0.1.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OREGE’s stock is considered to be overbought (>=80).
More news about OREGE.
3. ATENOR (ATEB.BR)
6.34% Price Change
Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, the United Kingdom, and Romania. The company develops real estate projects, such as offices and residential buildings. Atenor SA was founded in 1910 and is headquartered in La Hulpe, Belgium.
BEL 20 ended the session with ATENOR rising 6.34% to €28.50 on Friday, after two consecutive sessions in a row of gains. BEL 20 dropped 0.05% to €3,639.40, after two successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, ATENOR has a trailing twelve months EPS of €-0.12.
Volume
Today’s last reported volume for ATENOR is 5183 which is 30.38% above its average volume of 3975.
More news about ATENOR.
4. CM.COM (CMCOM.AS)
6.18% Price Change
CM.com N.V. provides cloud software for conversational commerce worldwide. It operates in four segments: Communication Platform as a Service (CPaaS), Software as a Service (SaaS), Payment Services, and Ticketing. Its products include Mobile Service Cloud, an all-in-one customer service software; Conversational AI Cloud for automating customer service with AI powered chats and voice bots; Mobile Marketing Cloud, an omnichannel customer engagement solution for businesses; Ticketing that offers event, seated, and attraction ticketing services; Sign, which allows the user to complete contracts, agreements, and documents without printing and scanning; communications platform for mobile messaging and voice for business communication; and payments platform that accepts online and POS payments. CM.com N.V. was founded in 1999 and is headquartered in Breda, the Netherlands.
AEX-Index ended the session with CM.COM jumping 6.18% to €9.80 on Friday, after two sequential sessions in a row of gains. AEX-Index fell 0.21% to €759.32, after four successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, CM.COM has a trailing twelve months EPS of €-1.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CM.COM’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
CM.COM’s stock is valued at €9.80 at 22:40 EST, way under its 52-week high of €15.94 and way higher than its 52-week low of €7.71.
Moving Average
CM.COM’s value is way higher than its 50-day moving average of €8.68 and below its 200-day moving average of €10.83.
More news about CM.COM.
5. NORTHERN DRILLING (NODL.OL)
5.73% Price Change
Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING rising 5.73% to €27.70 on Friday while Oslo Børs Benchmark Index_GI jumped 0.31% to €1,231.56.
Earnings Per Share
As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-4.09.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.69%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORTHERN DRILLING’s stock is considered to be overbought (>=80).
More news about NORTHERN DRILLING.
6. BELYSSE GROUP (BELYS.BR)
4.91% Price Change
Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.
BEL 20 ended the session with BELYSSE GROUP rising 4.91% to €1.18 on Friday while BEL 20 fell 0.05% to €3,639.40.
Earnings Per Share
As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.42.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELYSSE GROUP’s stock is considered to be overbought (>=80).
More news about BELYSSE GROUP.
7. THUNDERBIRD (TBIRD.AS)
4.84% Price Change
Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.
AEX-Index ended the session with THUNDERBIRD rising 4.84% to €0.07 on Friday, following the last session’s downward trend. AEX-Index fell 0.21% to €759.32, after four successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.01.
PE Ratio
THUNDERBIRD has a trailing twelve months price to earnings ratio of 6.5. Meaning, the purchaser of the share is investing €6.5 for every euro of annual earnings.
Volume
Today’s last reported volume for THUNDERBIRD is 32160 which is 8.77% below its average volume of 35252.
Volatility
THUNDERBIRD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.30%, a positive 0.36%, and a positive 7.26%.
THUNDERBIRD’s highest amplitude of average volatility was 7.74% (last week), 7.13% (last month), and 7.26% (last quarter).
More news about THUNDERBIRD.
8. AIRTHINGS (AIRX.OL)
4.67% Price Change
Airthings ASA, a hardware-enabled software company, develop products and systems for monitoring indoor air quality, radon, and energy efficiency worldwide. It operates through Consumer, Business, and Professional segments. The Consumer segments sells air quality sensors to private customers through retail and e-commerce. Its Business segment provides air quality solutions to schools, office building, and other commercial buildings. The Professional segment sells measurement solutions, which enables inspectors and certified radon professionals to measure, analyze, and report on buildings; and offers rental of products and calibration services. In addition, it offers digital radon detectors as well as smart indoor air quality monitors and solutions. The company provides its products under the View Plus, Wave Plus, Wave Radon, Wave Mini, House Kit, Hub, Corentium Home, Plus, and Pro brands. Airthings ASA was incorporated in 2008 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with AIRTHINGS jumping 4.67% to €2.58 on Friday while Oslo Børs Benchmark Index_GI rose 0.31% to €1,231.56.
Earnings Per Share
As for profitability, AIRTHINGS has a trailing twelve months EPS of kr-0.5.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.08%.
Volatility
AIRTHINGS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.14%, a positive 0.55%, and a positive 3.20%.
AIRTHINGS’s highest amplitude of average volatility was 2.85% (last week), 4.76% (last month), and 3.20% (last quarter).
Moving Average
AIRTHINGS’s worth is under its 50-day moving average of kr2.68 and way below its 200-day moving average of kr3.69.
More news about AIRTHINGS.
9. SCOR SE (SCR.PA)
4% Price Change
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and Asia Pacific. It operates in two segments, SCOR P&C and SCOR L&H. The SCOR P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, agricultural risks, and property catastrophes; specialties insurance products, including business solutions, political and credit risks, cyber, and environmental liability; and business ventures and partnerships. The SCOR L&H segment provides life reinsurance products, such as protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. This segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, balance sheet, solvency, and income improvements to clients; longevity solutions that include products covering the risk of negative deviation from expected results due to the insured or annuitant living longer than assumed in the pricing of insurance covers provided by insurers or pension funds; and distribution solutions. In addition, it is involved in the asset management business. The company was founded in 1970 and is headquartered in Paris, France.
CAC 40 ended the session with SCOR SE rising 4% to €24.43 on Friday while CAC 40 dropped 0.12% to €7,213.14.
Earnings Per Share
As for profitability, SCOR SE has a trailing twelve months EPS of €-1.69.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.57%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 204.4% and 160.5%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SCOR SE’s stock is considered to be overbought (>=80).
More news about SCOR SE.
10. AKVA GROUP (AKVA.OL)
3.96% Price Change
AKVA group ASA designs, purchases, manufactures, assembles, sells, and installs technology products; and provides rental and consulting services for the aquaculture industry. The company operates through three segments: Sea Based Technology (SBT), Digital, and Land Based Technology. The SBT segment offers plastic cages, steel cages, fish farming cages, feed barges, feed systems, sensor and camera systems, light systems, net cleaning systems, remotely operating vehicles, and nets and mooring systems under the Polarcirkel, Wavemaster, and Akvasmart hardware brands. This segment also supplies polyethylene boats and pipes to aquaculture and other industries, as well as plastic pen. The Digital segment provides production control, planning, traceability, and ERP software for the aquaculture and fishing industries under the Fishtalk, AKVAconnect, and AKVA Observe. The Land Based Technology segment designs and delivers recirculation systems for land-based fish farming, as well as provides water quality conditions for fresh and seawater operations. AKVA group ASA operates in Norway, Chile, the United Kingdom, Denmark, Canada, and internationally. The company was incorporated in 1982 and is based in Klepp Stasjon, Norway. AKVA group ASA is a subsidiary of Egersund Group AS.
Oslo Børs Benchmark Index_GI ended the session with AKVA GROUP rising 3.96% to €63.00 on Friday while Oslo Børs Benchmark Index_GI rose 0.31% to €1,231.56.
Earnings Per Share
As for profitability, AKVA GROUP has a trailing twelve months EPS of kr-4.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.65%.
Yearly Top and Bottom Value
AKVA GROUP’s stock is valued at kr63.00 at 22:40 EST, way below its 52-week high of kr84.60 and way above its 52-week low of kr46.50.
More news about AKVA GROUP.
Losers Today
1. AERKOMM INC (AKOM.PA)
-26.53% Price Change
Aerkomm Inc., together with its subsidiaries, focuses on providing in-flight entertainment and connectivity solutions in the Asian Pacific region. The company intends to offer airline passengers with broadband in-flight service options, such as Wi-Fi, cellular, movies, gaming, live TV, and music through built-in in-flight entertainment systems, such as seat-back displays, as well as on passengers' personal devices. It also focuses on providing content management services and e-commerce solutions; and AERKOMM K++ system, a IFEC system. The company is based in Fremont, California.
CAC 40 ended the session with AERKOMM INC falling 26.53% to €2.16 on Friday while CAC 40 fell 0.12% to €7,213.14.
Earnings Per Share
As for profitability, AERKOMM INC has a trailing twelve months EPS of €-1.37.
Volume
Today’s last reported volume for AERKOMM INC is 40 which is 1900% above its average volume of 2.
More news about AERKOMM INC.
2. NORDIC NANOVECTOR (NANOV.OL)
-18.68% Price Change
Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin's lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NORDIC NANOVECTOR dropping 18.68% to €2.29 on Friday, after five consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.31% to €1,231.56, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-7.91.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -304.6%.
Moving Average
NORDIC NANOVECTOR’s value is way above its 50-day moving average of kr0.78 and way above its 200-day moving average of kr1.09.
Volatility
NORDIC NANOVECTOR’s last week, last month’s, and last quarter’s current intraday variation average was 42.38%, 8.91%, and 5.94%.
NORDIC NANOVECTOR’s highest amplitude of average volatility was 42.38% (last week), 10.96% (last month), and 5.94% (last quarter).
Volume
Today’s last reported volume for NORDIC NANOVECTOR is 9540580 which is 803.05% above its average volume of 1056480.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORDIC NANOVECTOR’s stock is considered to be oversold (<=20).
More news about NORDIC NANOVECTOR.
3. GENTIAN DIAGNOSTIC (GENT.OL)
-8.1% Price Change
Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CRP) immunoassay, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine CRP in dog plasma and serum. It also provides turbidimetric SARS-CoV-2 total antibody immunoassay, a quantitative antibody test for detecting antibodies targeting the S1-subunit. Gentian Diagnostics ASA was incorporated in 2001 and is headquartered in Moss, Norway.
Oslo Børs Benchmark Index_GI ended the session with GENTIAN DIAGNOSTIC sliding 8.1% to €42.00 on Friday while Oslo Børs Benchmark Index_GI rose 0.31% to €1,231.56.
Earnings Per Share
As for profitability, GENTIAN DIAGNOSTIC has a trailing twelve months EPS of kr-1.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.94%.
Sales Growth
GENTIAN DIAGNOSTIC’s sales growth for the current quarter is 45.5%.
Moving Average
GENTIAN DIAGNOSTIC’s value is below its 50-day moving average of kr43.44 and higher than its 200-day moving average of kr41.36.
Yearly Top and Bottom Value
GENTIAN DIAGNOSTIC’s stock is valued at kr42.00 at 22:40 EST, way under its 52-week high of kr49.90 and way higher than its 52-week low of kr35.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 45.5%, now sitting on 122.43M for the twelve trailing months.
More news about GENTIAN DIAGNOSTIC.
4. EUROCASTLE INVEST. (ECT.AS)
-7.86% Price Change
Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.
AEX-Index ended the session with EUROCASTLE INVEST. falling 7.86% to €6.45 on Friday, following the last session’s upward trend. AEX-Index slid 0.21% to €759.32, after four sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, EUROCASTLE INVEST. has a trailing twelve months EPS of €-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.2%.
Moving Average
EUROCASTLE INVEST.’s worth is way under its 50-day moving average of €7.69 and way below its 200-day moving average of €8.54.
Volatility
EUROCASTLE INVEST.’s last week, last month’s, and last quarter’s current intraday variation average was 16.67%, 2.11%, and 6.45%.
EUROCASTLE INVEST.’s highest amplitude of average volatility was 16.67% (last week), 6.22% (last month), and 6.45% (last quarter).
More news about EUROCASTLE INVEST..
5. IMCD (IMCD.AS)
-7.07% Price Change
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers bioactives, biocides, chelates, functional additives, rheology modifiers, silicones, solubilisers, and solvents; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, binders, corrosion inhibitors, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
AEX-Index ended the session with IMCD sliding 7.07% to €133.35 on Friday, after three consecutive sessions in a row of losses. AEX-Index dropped 0.21% to €759.32, after four sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €5.5.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 24.25. Meaning, the purchaser of the share is investing €24.25 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
Moving Average
IMCD’s worth is under its 50-day moving average of €142.27 and under its 200-day moving average of €139.73.
Revenue Growth
Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 4.62B for the twelve trailing months.
Sales Growth
IMCD’s sales growth is 21.3% for the current quarter and 6.5% for the next.
Volatility
IMCD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.27%, a positive 0.25%, and a positive 1.26%.
IMCD’s highest amplitude of average volatility was 0.94% (last week), 1.10% (last month), and 1.26% (last quarter).
More news about IMCD.
6. EASE2PAY NV (EAS2P.AS)
-5.88% Price Change
Ease2pay N.V. provides online payment services and platform in the Netherlands. It offers payment transaction platform, which offers users services to order and pay in one action and parking solutions. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is headquartered in Waalwijk, the Netherlands. Ease2pay N.V. is a subsidiary of The Internet of Cars V.O.F.
AEX-Index ended the session with EASE2PAY NV sliding 5.88% to €0.80 on Friday while AEX-Index dropped 0.21% to €759.32.
Earnings Per Share
As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-0.1.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.6%.
Yearly Top and Bottom Value
EASE2PAY NV’s stock is valued at €0.80 at 22:40 EST, way under its 52-week high of €2.64 and way higher than its 52-week low of €0.57.
More news about EASE2PAY NV.
7. LAVIDE HOLDING (LVIDE.AS)
-5.88% Price Change
Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.
AEX-Index ended the session with LAVIDE HOLDING falling 5.88% to €0.32 on Friday while AEX-Index fell 0.21% to €759.32.
Earnings Per Share
As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.05.
Volume
Today’s last reported volume for LAVIDE HOLDING is 3660 which is 3.04% above its average volume of 3552.
Volatility
LAVIDE HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was 10.88%, 1.61%, and 8.22%.
LAVIDE HOLDING’s highest amplitude of average volatility was 10.88% (last week), 8.22% (last month), and 8.22% (last quarter).
Yearly Top and Bottom Value
LAVIDE HOLDING’s stock is valued at €0.32 at 22:40 EST, way under its 52-week high of €0.54 and way higher than its 52-week low of €0.14.
More news about LAVIDE HOLDING.
8. ABIVAX (ABVX.PA)
-5.5% Price Change
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that modulate the body's natural immune system to treat patients with chronic inflammatory, infectious, and cancer diseases. The company's products include obefazimod that is in Phase III clinical trials for the treatment of ulcerative colitis; Phase IIb clinical trials for the treatment of Crohn's Disease; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and in a pre-clinical trial for the treatment of Respiratory Syncytial Virus. It also develops ABX 196, an immune enhancer candidate that is in Phase 2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue, influenza, and respiratory syncytial virus. It has license agreement with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
CAC 40 ended the session with ABIVAX falling 5.5% to €15.12 on Friday while CAC 40 fell 0.12% to €7,213.14.
Earnings Per Share
As for profitability, ABIVAX has a trailing twelve months EPS of €-2.82.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -315.24%.
More news about ABIVAX.
9. MARTIFER (MAR.LS)
-4.91% Price Change
Martifer SGPS, S.A. operates in the metallic constructions and renewable energy development sectors worldwide. The company operates through Metallic Constructions, Naval Industry, and Renewables segments. The Metallic Constructions segment engages in the construction activities involving metal mechanical construction, aluminum, and glass façades, as well as infrastructures for oil and gas. The Naval Industry segment involved in shipbuilding, as well as provides ship repair services. The Renewables segment engages in the development of renewable energy projects, including wind and solar power projects. Martifer SGPS, S.A. was founded in 1990 and is headquartered in Oliveira de Frades, Portugal.
PSI ended the session with MARTIFER dropping 4.91% to €1.07 on Friday while PSI rose 0.22% to €5,966.71.
Earnings Per Share
As for profitability, MARTIFER has a trailing twelve months EPS of €0.14.
PE Ratio
MARTIFER has a trailing twelve months price to earnings ratio of 7.61. Meaning, the purchaser of the share is investing €7.61 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.03%.
More news about MARTIFER.
10. HYDROGENPRO (HYPRO.OL)
-4.84% Price Change
HydrogenPro ASA designs and supplies customized hydrogen plants. It provides high-pressure alkaline electrolysers. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.
Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO dropping 4.84% to €30.45 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.31% to €1,231.56, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.2.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.77%.
Sales Growth
HYDROGENPRO’s sales growth is 181.7% for the current quarter and 1889.6% for the next.
Volume
Today’s last reported volume for HYDROGENPRO is 87653 which is 11.93% above its average volume of 78304.
More news about HYDROGENPRO.
Stay up to date with our winners and losers daily report
